secwatch / observer
8-K filed February 28, 2025, 6:59 PM ET ticker KROS CIK 0001664710
other confidence high sentiment neutral materiality 0.10

Keros CEO to present at TD Cowen and Leerink healthcare conferences in March

Keros Therapeutics, Inc.

Keros Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001664710-25-000022
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.